https://www.selleckchem.com/
001) and RFS (p=0.0007), CONCLUSION The presence of LVSI in stage I-IIa clear cell carcinoma, mucinous /low grade serous and endometrioid ovarian cancer has an impact on OS and RFS and should put them at high risk and consider the option of adjuvant chemotherapy. Over the study period, 133 patients were included in the thirteen institutions. Among them, 12 patients had LVSI (9%). LVSI was an independent predictive factor for poorer Overall and recurrence free survivals. LVSI affected OS (p less then 0.001) and RFS (p = 0.0007), CONCLUSION The presence of LV
Like
Comment
Share
